PT1220858E - Oxazinoquinolonas uteis para o tratamento de infeccoes virais - Google Patents
Oxazinoquinolonas uteis para o tratamento de infeccoes viraisInfo
- Publication number
- PT1220858E PT1220858E PT00966694T PT00966694T PT1220858E PT 1220858 E PT1220858 E PT 1220858E PT 00966694 T PT00966694 T PT 00966694T PT 00966694 T PT00966694 T PT 00966694T PT 1220858 E PT1220858 E PT 1220858E
- Authority
- PT
- Portugal
- Prior art keywords
- oxazinoquinolones
- uteis
- treatment
- viral infections
- infections
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15774299P | 1999-10-05 | 1999-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1220858E true PT1220858E (pt) | 2004-03-31 |
Family
ID=22565065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00966694T PT1220858E (pt) | 1999-10-05 | 2000-09-28 | Oxazinoquinolonas uteis para o tratamento de infeccoes virais |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6340680B1 (pt) |
| EP (1) | EP1220858B1 (pt) |
| JP (1) | JP2003511382A (pt) |
| AR (1) | AR032598A1 (pt) |
| AT (1) | ATE253578T1 (pt) |
| AU (1) | AU773098B2 (pt) |
| CA (1) | CA2382691A1 (pt) |
| CO (1) | CO5251424A1 (pt) |
| DE (1) | DE60006412T2 (pt) |
| DK (1) | DK1220858T3 (pt) |
| ES (1) | ES2210001T3 (pt) |
| NZ (1) | NZ518189A (pt) |
| PE (1) | PE20010598A1 (pt) |
| PT (1) | PT1220858E (pt) |
| TW (1) | TW500724B (pt) |
| WO (1) | WO2001025239A2 (pt) |
| ZA (1) | ZA200201556B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6673793B2 (en) | 2000-07-12 | 2004-01-06 | Pharmacia & Upjohn Co. | Oxazinoquinolones useful for the treatment of viral infections |
| US6624159B2 (en) * | 2000-07-12 | 2003-09-23 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| DE60105614T2 (de) * | 2000-07-12 | 2005-10-06 | Pharmacia & Upjohn Co., Kalamazoo | Oxazinochinolone für die behandlung viraler infektionen |
| US6821969B2 (en) * | 2001-02-13 | 2004-11-23 | Pharmacia & Upjohn Company | Thioxazinoquinolones as antiviral agents |
| BR0215067A (pt) * | 2001-12-20 | 2004-11-09 | Upjohn Co | Piridoquinoxalinas antivirais |
| MXPA04006041A (es) * | 2001-12-20 | 2004-09-27 | Upjohn Co | Antivirales de piridoquinoxalina. |
| US20040186131A1 (en) * | 2002-08-30 | 2004-09-23 | Wathen Michael W | Method of preventing or treating atherosclerosis or restenosis |
| WO2004019933A1 (en) * | 2002-08-30 | 2004-03-11 | Pharmacia & Upjohn Company | Method of preventing or treating atherosclerosis or restenosis |
| CA2530352A1 (en) | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | Quinolone derivative or salt thereof |
| AU2019339777B2 (en) | 2018-09-12 | 2022-09-01 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| CN114667285A (zh) | 2019-09-26 | 2022-06-24 | 诺华股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4568649A (en) | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
| US4870168A (en) | 1987-02-26 | 1989-09-26 | Bristol-Myers Company | 3-Unsaturated alkyl cephems from 3-triflyl cephems |
| TW222276B (pt) | 1992-01-27 | 1994-04-11 | Fujisawa Pharmaceutical Co | |
| US5792774A (en) | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
| EP0927164A1 (en) | 1996-09-10 | 1999-07-07 | PHARMACIA & UPJOHN COMPANY | 8-hydroxy-7-substituted quinolines as anti-viral agents |
-
2000
- 2000-09-08 TW TW089118456A patent/TW500724B/zh not_active IP Right Cessation
- 2000-09-15 PE PE2000000954A patent/PE20010598A1/es not_active Application Discontinuation
- 2000-09-22 AR ARP000104986A patent/AR032598A1/es unknown
- 2000-09-28 NZ NZ518189A patent/NZ518189A/en unknown
- 2000-09-28 DE DE60006412T patent/DE60006412T2/de not_active Expired - Fee Related
- 2000-09-28 CA CA002382691A patent/CA2382691A1/en not_active Abandoned
- 2000-09-28 AT AT00966694T patent/ATE253578T1/de not_active IP Right Cessation
- 2000-09-28 WO PCT/US2000/021985 patent/WO2001025239A2/en active IP Right Grant
- 2000-09-28 AU AU77001/00A patent/AU773098B2/en not_active Ceased
- 2000-09-28 EP EP00966694A patent/EP1220858B1/en not_active Expired - Lifetime
- 2000-09-28 JP JP2001528183A patent/JP2003511382A/ja active Pending
- 2000-09-28 PT PT00966694T patent/PT1220858E/pt unknown
- 2000-09-28 US US09/672,472 patent/US6340680B1/en not_active Expired - Fee Related
- 2000-09-28 ES ES00966694T patent/ES2210001T3/es not_active Expired - Lifetime
- 2000-09-28 DK DK00966694T patent/DK1220858T3/da active
- 2000-10-03 CO CO00074929A patent/CO5251424A1/es not_active Application Discontinuation
-
2002
- 2002-02-25 ZA ZA200201556A patent/ZA200201556B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ518189A (en) | 2004-05-28 |
| AU7700100A (en) | 2001-05-10 |
| CA2382691A1 (en) | 2001-04-12 |
| AU773098B2 (en) | 2004-05-13 |
| TW500724B (en) | 2002-09-01 |
| DE60006412D1 (de) | 2003-12-11 |
| WO2001025239A3 (en) | 2001-11-22 |
| PE20010598A1 (es) | 2001-05-24 |
| US6340680B1 (en) | 2002-01-22 |
| JP2003511382A (ja) | 2003-03-25 |
| ZA200201556B (en) | 2003-07-30 |
| EP1220858A2 (en) | 2002-07-10 |
| ATE253578T1 (de) | 2003-11-15 |
| CO5251424A1 (es) | 2003-02-28 |
| WO2001025239A2 (en) | 2001-04-12 |
| AR032598A1 (es) | 2003-11-19 |
| DK1220858T3 (da) | 2004-01-26 |
| DE60006412T2 (de) | 2004-08-26 |
| EP1220858B1 (en) | 2003-11-05 |
| ES2210001T3 (es) | 2004-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200200172A (et) | Ühendid isheemia ravimiseks | |
| PT1147083E (pt) | Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao | |
| PT956858E (pt) | Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais | |
| ID26043A (id) | Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv | |
| PT1210113E (pt) | Composicoes de vacinas de combinacao | |
| FI20000564A (fi) | Menetelmä nanolaminaattien valmistamiseksi | |
| NO20014379L (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
| PL376454A1 (en) | 1-acyl-pyrrolidine derivatives for the treatment of viral infections | |
| IS2567B (is) | Samsetningar gegn veirum | |
| FI20000863A (fi) | Uusi hoitomenetelmä | |
| DK1176964T3 (da) | Brug af ET743 til behandling af cancer | |
| PT1206436E (pt) | Retinoides para o tratamento de enfisema | |
| PT1154777E (pt) | Medicamento para o tratamento de hipertensao arterial | |
| PT1299395E (pt) | Oxazinoquinolonas uteis para o tratamento de infeccoes provocadas por virus | |
| ES1044448Y (es) | Auto-aplicador de vendaje | |
| DE60021065D1 (de) | Virus behandlung | |
| PT1220858E (pt) | Oxazinoquinolonas uteis para o tratamento de infeccoes virais | |
| DE60227963D1 (de) | Behandlungssystem | |
| NO20022816D0 (no) | Behandling av virale infeksjoner ved anvendelse av Levovirin | |
| PT1268482E (pt) | Piranoindois para o tratamento de glaucoma | |
| NO20032769L (no) | Kombinasjonsmetode for behandling av virale infeksjoner | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| AP2002002432A0 (en) | Treatment of viral infections | |
| PT1200447E (pt) | Oxazinocarbazoles para o tratamento de doencas do snc | |
| DE60011060D1 (de) | Virus behandlung |